Login / Signup

Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.

Ali BidariSara AsgarianArash Pour MohammadDelaram NaderiShiva Rahimipour AnarakiMilad Gholizadeh MesgarhaMahya Naderkhani
Published in: European journal of haematology (2022)
De novo ITP is a rare complication of COVID-19 vaccination, and corresponding reports belong to mRNA-based and adenovirus vector-based vaccines, in order of frequency. This frequency pattern may be related to the scale of administration of individual vaccines and their potency in inducing autoimmunity. The more the COVID-19 vaccine is potent to induce antigenic challenge, the shorter the lag time would be. Most patients had a benign course and responded to typical treatments of primary ITP.
Keyphrases
  • coronavirus disease
  • sars cov
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • respiratory syndrome coronavirus
  • peritoneal dialysis
  • gene therapy
  • drug induced